Gulf International Cancer Center (GICC) has treated 6,682 patients through its radiation therapy services, alongside recording 21,196 medical oncology cases and conducting 22,573 Positron Emission Tomography/Computed Tomography (PET/CT) examinations.
The figures highlight the centre’s clinical activity since its establishment in 2007 and its role in providing specialised cancer diagnosis and treatment services in Abu Dhabi.
GICC offers medical oncology, radiation therapy and advanced diagnostic imaging, bringing these services together to support diagnosis, treatment planning and patient monitoring.
Cancer treatment services and personalised care
The centre uses radiation oncology and medical oncology as part of its cancer treatment services.
Advances in medical imaging and radiation delivery allow doctors to target tumours more precisely while seeking to reduce exposure to surrounding healthy tissues.
Medical oncology services include systemic treatment approaches, with decisions based on factors such as cancer type, disease stage and the patient’s medical condition.
The centre also focuses on individualised treatment plans, allowing specialists to assess patients and monitor their response to treatment throughout different stages of care.
GICC achieves six JCI accreditations
GICC has received Joint Commission International (JCI) accreditation six times, according to the centre.
The accreditation reflects its focus on internationally recognised healthcare quality and patient safety standards.
Dr Ali Abdelrazek, Executive Director and Head of Radiation Oncology at Gulf International Cancer Center, said: “Over nearly two decades, cancer care has undergone significant changes, particularly in how we diagnose tumours, plan treatment and deliver radiation therapy. These developments have strengthened our ability to tailor treatment approaches to the individual needs of each patient.
“At Gulf International Cancer Center, our focus has always been on combining clinical expertise with internationally recognised standards of care. Every patient requires careful assessment and an individualised treatment strategy, and our responsibility is to ensure that treatment decisions are guided by medical evidence, precision and patient safety.”
Abu Dhabi and Sharjah centres strengthen collaboration
GICC’s experience also supports knowledge exchange and professional collaboration with its sister company, Advanced Diagnostic & Oncology Center (ADOC), located in Sharjah Healthcare City.
The two centres share specialised medical expertise, clinical knowledge and oncology practices, with the aim of supporting the development of specialised cancer services across the UAE.
The collaboration provides a link between oncology services in Abu Dhabi and Sharjah as both centres continue to focus on clinical expertise and patient-centred care.